# Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

> **NCT04275557** · — · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 1174 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Cyst

## Interventions

- **OTHER:** Blood Sample collection
- **OTHER:** Tissue sample collection
- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04275557
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-18
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 1174 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275557, "Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04275557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*